Viewing Study NCT07008703


Ignite Creation Date: 2025-12-24 @ 7:21 PM
Ignite Modification Date: 2026-03-26 @ 10:19 PM
Study NCT ID: NCT07008703
Status: RECRUITING
Last Update Posted: 2025-06-06
First Post: 2024-01-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module